Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.

Allyse M, Michie M.

Trends Biotechnol. 2013 Aug;31(8):439-41. doi: 10.1016/j.tibtech.2013.04.006. No abstract available.

2.
3.

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG; American College of Medical Genetics and Genomics..

Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73.

5.

Towards a European consensus for reporting incidental findings during clinical NGS testing.

Hehir-Kwa JY, Claustres M, Hastings RJ, van Ravenswaaij-Arts C, Christenhusz G, Genuardi M, Melegh B, Cambon-Thomsen A, Patsalis P, Vermeesch J, Cornel MC, Searle B, Palotie A, Capoluongo E, Peterlin B, Estivill X, Robinson PN.

Eur J Hum Genet. 2015 Dec;23(12):1601-6. doi: 10.1038/ejhg.2015.111.

6.

Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.

Smith LA, Douglas J, Braxton AA, Kramer K.

J Genet Couns. 2015 Aug;24(4):654-62. doi: 10.1007/s10897-014-9794-4.

PMID:
25403901
7.

Molecular findings among patients referred for clinical whole-exome sequencing.

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, Veeraraghavan N, Hawes A, Chiang T, Leduc M, Beuten J, Zhang J, He W, Scull J, Willis A, Landsverk M, Craigen WJ, Bekheirnia MR, Stray-Pedersen A, Liu P, Wen S, Alcaraz W, Cui H, Walkiewicz M, Reid J, Bainbridge M, Patel A, Boerwinkle E, Beaudet AL, Lupski JR, Plon SE, Gibbs RA, Eng CM.

JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.

8.

Recommendations for returning genomic incidental findings? We need to talk!

Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H, Uhlmann WR, Wilfond B, Wolf SM, Zimmern R.

Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Review.

9.

Clinical exome performance for reporting secondary genetic findings.

Park JY, Clark P, Londin E, Sponziello M, Kricka LJ, Fortina P.

Clin Chem. 2015 Jan;61(1):213-20. doi: 10.1373/clinchem.2014.231456.

10.

Taxonomizing, sizing, and overcoming the incidentalome.

Kohane IS, Hsing M, Kong SW.

Genet Med. 2012 Apr;14(4):399-404. doi: 10.1038/gim.2011.68.

11.

Genomic test validation for incidental findings.

Park JY, Fortina P, Kricka LJ.

Clin Chem. 2014 Feb;60(2):292-3. doi: 10.1373/clinchem.2013.210609. No abstract available.

12.

[Ethical issues in genome-era].

Kosugi S.

Nihon Rinsho. 2016 Jun;74(6):1022-7. Review. Japanese.

PMID:
27311196
13.

Incidental medical information in whole-exome sequencing.

Solomon BD, Hadley DW, Pineda-Alvarez DE; NISC Comparative Sequencing Program., Kamat A, Teer JK, Cherukuri PF, Hansen NF, Cruz P, Young AC, Berkman BE, Chandrasekharappa SC, Mullikin JC.

Pediatrics. 2012 Jun;129(6):e1605-11. doi: 10.1542/peds.2011-0080.

14.

Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines.

Anderson JA, Hayeems RZ, Shuman C, Szego MJ, Monfared N, Bowdin S, Zlotnik Shaul R, Meyn MS.

Clin Genet. 2015 Apr;87(4):301-10. doi: 10.1111/cge.12460. Review.

PMID:
25046648
15.

Point-counterpoint. Ethics and genomic incidental findings.

McGuire AL, Joffe S, Koenig BA, Biesecker BB, McCullough LB, Blumenthal-Barby JS, Caulfield T, Terry SF, Green RC.

Science. 2013 May 31;340(6136):1047-8. doi: 10.1126/science.1240156. No abstract available.

16.

Ethical and legal implications of whole genome and whole exome sequencing in African populations.

Wright GE, Koornhof PG, Adeyemo AA, Tiffin N.

BMC Med Ethics. 2013 May 28;14:21. doi: 10.1186/1472-6939-14-21.

17.

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

Rosenblatt DS.

Mol Genet Metab. 2013 Sep-Oct;110(1-2):1-2. doi: 10.1016/j.ymgme.2013.06.001. No abstract available.

PMID:
23809103
18.

ACMG clinical laboratory standards for next-generation sequencing.

Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E; Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee..

Genet Med. 2013 Sep;15(9):733-47. doi: 10.1038/gim.2013.92.

19.

The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.

Lawrence L, Sincan M, Markello T, Adams DR, Gill F, Godfrey R, Golas G, Groden C, Landis D, Nehrebecky M, Park G, Soldatos A, Tifft C, Toro C, Wahl C, Wolfe L, Gahl WA, Boerkoel CF.

Genet Med. 2014 Oct;16(10):741-50. doi: 10.1038/gim.2014.29.

20.

The impact of reporting incidental findings from exome and whole-genome sequencing: predicted frequencies based on modeling.

Ding LE, Burnett L, Chesher D.

Genet Med. 2015 Mar;17(3):197-204. doi: 10.1038/gim.2014.94.

Supplemental Content

Support Center